Cited In for PMID: 23863845

Year	Number of Results
2013	3
2014	3
2015	3
2016	1
2017	1
2018	3
2019	4
2020	7
2021	4
2022	4
2023	3
2024	0

1

Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein-DNA interactions.

Eldar A, Rozenberg H, Diskin-Posner Y, Rohs R, Shakked Z. Eldar A, et al. Nucleic Acids Res. 2013 Oct;41(18):8748-59. doi: 10.1093/nar/gkt630. Epub 2013 Jul 17. Nucleic Acids Res. 2013. PMID: 23863845 Free PMC article.

2

Challenges and Prospects of Patient-Derived Xenografts for Cancer Research.

Jin J, Yoshimura K, Sewastjanow-Silva M, Song S, Ajani JA. Jin J, et al. Cancers (Basel). 2023 Aug 31;15(17):4352. doi: 10.3390/cancers15174352. Cancers (Basel). 2023. PMID: 37686627 Free PMC article. Review.

3

Small-molecule correctors and stabilizers to target p53.

Fallatah MMJ, Law FV, Chow WA, Kaiser P. Fallatah MMJ, et al. Trends Pharmacol Sci. 2023 May;44(5):274-289. doi: 10.1016/j.tips.2023.02.007. Epub 2023 Mar 22. Trends Pharmacol Sci. 2023. PMID: 36964053 Review.

4

Targeting p53 pathways: mechanisms, structures, and advances in therapy.

Wang H, Guo M, Wei H, Chen Y. Wang H, et al. Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1. Signal Transduct Target Ther. 2023. PMID: 36859359 Free PMC article. Review.

5

Discovery of compounds that reactivate p53 mutants in vitro and in vivo.

Durairaj G, Demir Ö, Lim B, Baronio R, Tifrea D, Hall LV, DeForest JC, Lauinger L, Jebril Fallatah MM, Yu C, Bae H, Lin DW, Kim JK, Salehi F, Jang C, Qiao F, Lathrop RH, Huang L, Edwards R, Rychnovsky S, Amaro RE, Kaiser P. Durairaj G, et al. Cell Chem Biol. 2022 Sep 15;29(9):1381-1395.e13. doi: 10.1016/j.chembiol.2022.07.003. Epub 2022 Aug 10. Cell Chem Biol. 2022. PMID: 35948006 Free PMC article.

6

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.

Hassin O, Nataraj NB, Shreberk-Shaked M, Aylon Y, Yaeger R, Fontemaggi G, Mukherjee S, Maddalena M, Avioz A, Iancu O, Mallel G, Gershoni A, Grosheva I, Feldmesser E, Ben-Dor S, Golani O, Hendel A, Blandino G, Kelsen D, Yarden Y, Oren M. Hassin O, et al. Nat Commun. 2022 May 19;13(1):2800. doi: 10.1038/s41467-022-30481-7. Nat Commun. 2022. PMID: 35589715 Free PMC article.

7

Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog.

Zhang Q, Balourdas DI, Baron B, Senitzki A, Haran TE, Wiman KG, Soussi T, Joerger AC. Zhang Q, et al. Cell Death Dis. 2022 Mar 7;13(3):214. doi: 10.1038/s41419-022-04653-8. Cell Death Dis. 2022. PMID: 35256607 Free PMC article.

8

Most Probable Druggable Pockets in Mutant p53-Arg175His Clusters Extracted from Gaussian Accelerated Molecular Dynamics Simulations.

Mustafa M, Gharaibeh M. Mustafa M, et al. Protein J. 2022 Feb;41(1):27-43. doi: 10.1007/s10930-022-10041-0. Epub 2022 Jan 31. Protein J. 2022. PMID: 35099676

9

Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ).

Degtjarik O, Golovenko D, Diskin-Posner Y, Abrahmsén L, Rozenberg H, Shakked Z. Degtjarik O, et al. Nat Commun. 2021 Dec 3;12(1):7057. doi: 10.1038/s41467-021-27142-6. Nat Commun. 2021. PMID: 34862374 Free PMC article.

10

Structural and Drug Targeting Insights on Mutant p53.

Gomes AS, Ramos H, Inga A, Sousa E, Saraiva L. Gomes AS, et al. Cancers (Basel). 2021 Jul 3;13(13):3344. doi: 10.3390/cancers13133344. Cancers (Basel). 2021. PMID: 34283062 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

33 results

Results by year